Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$1.22K 296
2026
Q1
$1.22K Buy
100
+99
+9,900% +$35.3K ﹤0.01% 293
2025
Q4
$172 Buy
+1
New +$317 ﹤0.01% 283

Other funds holding AMGN

Royal Fund Management's AMGN Position: Q2 2026 in Review

Royal Fund Management increased its Amgen (AMGN) stake by 5.6% in Q2 2026, buying an estimated $403K and bringing the position to 22,196 shares worth $8.04M. The position accounts for 0.67% of the portfolio, ranked #42.

Royal Fund Management first reported a position in AMGN in Q2 2017 and has held it in 36 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Royal Fund Management held 22,196 shares of Amgen worth $8.04M as of Q2 2026.
  • Royal Fund Management bought 1,177 Amgen shares in Q2 2026, an estimated $403K.
  • Amgen made up 0.67% of Royal Fund Management's portfolio in Q2 2026, its #42 holding.
  • Royal Fund Management first reported a position in Amgen in Q2 2017 and has held it in 36 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.